Financhill
Back

INmune Bio Stock Predictions

INmune Bio Stock Forecast

  • Is INmune Bio Stock Undervalued?
    The current INmune Bio [INMB] share price is $4.80. The Score for INMB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will INmune Bio Stock Go Up Next Year?

Data Unavailable

INmune Bio Stock Rating

Data Unavailable

INmune Bio Stock Price History

Is INMB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inmunebio.com

52-Week Data

52-Week High:
14.74
52-Week Low:
4.45

Prediction Charts

Market Cap:
106.43M
Price in USD:
4.80
Volume:
178.71K
Beta:
1.85

Technical Analysis

SMA50:
5.38
SMA100:
6.42
SMA200:
8.52
52-Wk Change:
-48.44%

Stock Predictions

  • Is INmune Bio stock public?
    Yes, INmune Bio is a publicly traded company.
  • What is the INmune Bio stock quote today?
    The INmune Bio stock price is 4.80 USD today.
  • How to buy INmune Bio stock online?
    You can buy INmune Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-6 6.39 6.44 6.59 6.24
Nov-7 6.46 6.22 6.50 6.11
Nov-8 6.20 6.13 6.22 6.09
Nov-11 6.14 6.13 6.26 6.09
Nov-12 6.04 5.66 6.17 5.65
Nov-13 5.71 5.73 5.97 5.60
Nov-14 5.67 5.44 5.67 5.42
Nov-15 5.30 4.96 5.34 4.91
Nov-18 5.00 4.87 5.08 4.81
Nov-19 4.80 4.71 4.82 4.60
Nov-20 4.70 4.56 4.70 4.45
Nov-21 4.56 4.76 4.86 4.47
Nov-22 4.76 4.87 4.98 4.70
Nov-25 4.93 4.80 5.10 4.80

INmune Bio Earnings

Data Unavailable

INmune Bio Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and an increase next year of $0.25 per share.

* INmune Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.